Researchers have uncovered a new understanding of levodopa-induced dyskinesia, a common side effect in Parkinson’s patients, ...

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's ...

University of Arizona researchers uncovered how levodopa-induced dyskinesia disrupts motor cortex function in Parkinson’s ...

The standard medication levodopa does not always work against tremors in Parkinson's disease, especially in stressful ...

Nominally significant effects were seen in levodopa users (HR=0.79, p=0.0431) and covariate-adjusted analyses (HR=0.81, ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

While prasinezumab led to a numerical delay in motor progression without statistical significance, the effect was even more ...

For this reason, people with Parkinson’s usually take levodopa in combination with another drug, carbidopa, that inhibits the break down. Researchers have been working to see how much of a role ...

The effect of prasinezumab was more pronounced in a pre-specified analysis in the population treated with levodopa (75% of participants), HR=0.79 [0.63-0.99] and nominal p=0.0431. Pre-specified ...

Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. Wh ...

PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory endpoints </ ...